Artificial Intelligence a Key Growth Enabler for UAE's Healthcare Sector: Al Zahra Hospital

DUBAI, UAE - July 28, 2019 - PRLog -- Al Zahra Hospital Dubai (AZHD), striving to embody the principles propagated by the 'UAE Vision 2021 National Agenda for Health', is aiming to be one of the early adopters of Artificial Intelligence (AI) backed technologies. To fast-track this process, AZHD has further strengthened its partnership with Siemens Healthineers', one of the largest healthcare providers in the world.

Healthcare specialists are often challenged with unwanted variability and inconsistent results, when people of different physiologies and anatomies are examined during MRI examinations and ultrasound imaging. In an attempt to overcome these challenges, clinicians have traditionally compromised on ultrasound image resolution, or penetration of their ultrasound imaging.

"Around 47.5 percent of UAE residents are overweight, and close to 13 percent are obese. To address this challenge on an urgent basis, AZHD's adoption of Siemens Healthineers' newly released ACUSON Sequoia ultrasound system, with its higher penetration capabilities, now equips the hospital to accurately diagnose patients with larger body types," stated Dr. Mohaymen Abdelghany, CEO of Al Zahra Hospital Dubai (AZHD).

ACUSON Sequoia's new BioAcoustic imaging technology accurately represents human biology and tracks the ultrasound signal throughout the signal path for a high quality image.

"AZHD will be one of the early adopters in the UAE to install the state-of-the-art high-tech MRI and Ultrasound systems to provide accurate diagnostic support to its different current and future certified centers of excellence in AZHD such as orthopaedics and sports injuries, bariatrics and metabolic surgery, minimally invasive gynaecology, oncology and cardiology in a major step to pursue our vision of leading the region in clinical outcome and patient experience.

"Fast MRI sequences and protocols will enable AZHD to increase imaging quality, minimize post-surgical image discrepancy from 8 to 2% and achieve its same day MRI objective by reducing the MRI wait list. An additional 20 patients will benefit daily from the latest MRI MAGNETOM Vida equipped with the BioMatrix artificial intelligence technology," added Dr. Mohaymen.

The MAGNETOM Vida, aims to personalise MRI scans by overcoming patient biovariability, that is the individual's unique characteristics rather than being seen as an impediment when it comes to MRI scanning. MAGNETOM Vida with BioMatrix Technology gives reproducible image quality and comprehensive clinical information irrespective of the patient or system operator.